Literature DB >> 7902623

Smooth muscle cell proliferation and localization of macrophages and T cells in the occlusive intracranial major arteries in moyamoya disease.

J Masuda1, J Ogata, C Yutani.   

Abstract

BACKGROUND AND
PURPOSE: Stenosis or occlusion due to fibrocellular intimal thickening in the intracranial major arteries is thought to be the primary lesion in moyamoya disease, but its etiology and pathogenesis are unknown. The present study was designed to analyze cellular components of the lesions and their pathological process.
METHODS: Stenotic or occlusive intracranial arterial lesions were collected from six autopsied patients who died of moyamoya disease. The cellular components were analyzed by immunohistochemical staining using cell-type-specific monoclonal antibodies. The sections were also immunostained for proliferating cell nuclear antigen (PCNA) to detect proliferating cells and for two different types of intermediate filaments, desmin and vimentin, to evaluate phenotypes of the intimal smooth muscle cells.
RESULTS: The thickened intima was composed predominantly of smooth muscle cells with an admixture of some macrophages and T cells. Macrophages and T cells were scattered in the superficial layer of the intimal thickening, and these were occasionally associated with organization of fibrin thrombi. Proliferating smooth muscle cells, indicated by PCNA-positive nuclei and muscle actin-positive cytoplasm, were found in the thickened intima in four patients. Immunohistochemical staining for intermediate filaments revealed intimal smooth muscle cells showing positive staining for vimentin and negative staining for desmin, compatible with the phenotype of synthetic smooth muscle cells.
CONCLUSIONS: The present study provides evidence that smooth muscle cells are proliferating in the occlusive lesions in intracranial major arteries in moyamoya disease. The colocalization of inflammatory cells and PCNA-positive cells suggests that inflammatory stimuli may induce proliferative response of smooth muscle and contribute to the formation of the intracranial occlusive lesions in moyamoya disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7902623     DOI: 10.1161/01.str.24.12.1960

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  39 in total

1.  Comparative analysis of serum proteomes of moyamoya disease and normal controls.

Authors:  Eun-Jeong Koh; Han-Na Kim; Tian-Ze Ma; Ha-Young Choi; Yong-Geun Kwak
Journal:  J Korean Neurosurg Soc       Date:  2010-07-31

2.  Smooth muscle immaturity in the carotid arterial neointima as a prognostic marker for systemic atherogenic cardiovascular events in the Asian male.

Authors:  Hirotsugu Hashimoto; Atsushi Kurata; Tamaki Nashiro; Shigeru Inoue; Tomonori Ushijima; Koji Fujita; Toshikazu Kimura; Kensuke Kawai; Hajime Horiuchi; Masahiko Kuroda
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

3.  Added Value of Vessel Wall Magnetic Resonance Imaging in the Differentiation of Moyamoya Vasculopathies in a Non-Asian Cohort.

Authors:  Mahmud Mossa-Basha; Adam de Havenon; Kyra J Becker; Danial K Hallam; Michael R Levitt; Wendy A Cohen; Daniel S Hippe; Matthew D Alexander; David L Tirschwell; Thomas Hatsukami; Catherine Amlie-Lefond; Chun Yuan
Journal:  Stroke       Date:  2016-06-07       Impact factor: 7.914

4.  Moyamoya disease in adults: the role of cerebral revascularization.

Authors:  Gregory J Zipfel; Douglas J Fox; Dennis J Rivet
Journal:  Skull Base       Date:  2005-02

5.  De novo ACTA2 mutation causes a novel syndrome of multisystemic smooth muscle dysfunction.

Authors:  Dianna M Milewicz; John R Østergaard; Leena M Ala-Kokko; Nadia Khan; Dorothy K Grange; Roberto Mendoza-Londono; Timothy J Bradley; Ann Haskins Olney; Lesley Adès; Joseph F Maher; Dongchuan Guo; L Maximilian Buja; Dong Kim; James C Hyland; Ellen S Regalado
Journal:  Am J Med Genet A       Date:  2010-10       Impact factor: 2.802

Review 6.  Progress in moyamoya disease.

Authors:  Shuling Shang; Da Zhou; Jingyuan Ya; Sijie Li; Qi Yang; Yuchuan Ding; Xunming Ji; Ran Meng
Journal:  Neurosurg Rev       Date:  2018-06-18       Impact factor: 3.042

7.  Identification of novel biomarker candidates by proteomic analysis of cerebrospinal fluid from patients with moyamoya disease using SELDI-TOF-MS.

Authors:  Yoshio Araki; Kazuhiro Yoshikawa; Sho Okamoto; Masaki Sumitomo; Mikio Maruwaka; Toshihiko Wakabayashi
Journal:  BMC Neurol       Date:  2010-11-08       Impact factor: 2.474

8.  Intracranial atherosclerotic disease associated with moyamoya collateral formation: histopathological findings.

Authors:  Thomas Jiang; Arie Perry; Ralph G Dacey; Gregory J Zipfel; Colin P Derdeyn
Journal:  J Neurosurg       Date:  2013-02-08       Impact factor: 5.115

Review 9.  Vessel wall imaging for intracranial vascular disease evaluation.

Authors:  Mahmud Mossa-Basha; Matthew Alexander; Santhosh Gaddikeri; Chun Yuan; Dheeraj Gandhi
Journal:  J Neurointerv Surg       Date:  2016-01-14       Impact factor: 5.836

10.  Serum alpha1-antitrypsin level and phenotype associated with familial moyamoya disease.

Authors:  Toshiyuki Amano; Satoshi Inoha; Chun-Ming Wu; Toshio Matsushima; Kiyonobu Ikezaki
Journal:  Childs Nerv Syst       Date:  2003-07-25       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.